An AllTrials project

NCT04292730: A reported trial by Gilead Sciences

This trial has reported on time, in line with the regulations.

Full data

Full entry on ClinicalTrials.gov NCT04292730
Title A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate COVID-19 Compared to Standard of Care Treatment
Results Status Reported
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date March 15, 2020
Completion date April 29, 2020
Required reporting date April 29, 2021, midnight
Actual reporting date Dec. 15, 2020
Date last checked at ClinicalTrials.gov Feb. 9, 2024
Days late None